FDA Approves Dapagliflozin for Type 2 Diabetes (FREE)

By Amy Orciari Herman Dapagliflozin (Farxiga) — an inhibitor of sodium-glucose co-transporter 2 — has been approved as an adjunct to diet and exercise in adults with type 2 diabetes, the …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news